David M. Taylor, PhD, MRPharmS | Psychiatrist.com

Original Research

Risperidone Long-Acting Injection: A Prospective 3-Year Analysis of Its Use in Clinical Practice

November 18, 2009

David M. Taylor, Catrin Fischetti, Anna Sparshatt, et al

Original Research

Outcome Following Clozapine Discontinuation: A Retrospective Analysis

July 16, 2007

David M. Taylor, James M. Atkinson, Petrina Douglas-Hall, et al

Original Research

Early Clinical Experience With Risperidone Long-Acting Injection: A Prospective, 6-Month Follow-Up of 100 Patients

August 16, 2004

David M. Taylor, Corina L. Young, Shubhra Mace, et al

Letter to the Editor

Reply to "Comments on Cost Analysis of Risperidone Versus Olanzapine"

June 1, 2004

David M. Taylor

Original Research

How Effective Is St. John's Wort? The Evidence Revisited

May 1, 2004

David M. Taylor, Urula Werneke, Oded Horn

Original Research

Risperidone Compared With Olanzapine in a Naturalistic Clinical Study: A Cost Analysis

May 15, 2003

David M. Taylor, Susan E. Libretto, Tim Wright

Original Research

Prior Antipsychotic Prescribing in Patients Currently Receiving Clozapine: A Case Note Review

January 15, 2003

David M. Taylor, Corina Young, Carol Paton